SNY Jul 2024 45.000 call
| Previous Close | 4.2000 |
| Open | 3.6000 |
| Bid | 3.4000 |
| Ask | 5.8000 |
| Strike | 45.00 |
| Expire Date | 2024-07-19 |
| Day's Range | 3.6000 - 4.2000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 52 |
GlobeNewswirePress Release: Availability of the Q2 2024 Aide-mémoire
Availability of the Q2 2024 Aide-mémoire Paris, France – June 25, 2024. Sanofi announced that its Q2 2024 Aide-mémoire is available on the "Investors" page of the company's website: https://www.sanofi.com/en/investors/financial-results-and-events/financial-results/q2-results-2024 As for each quarter, Sanofi prepared this document to assist in the financial modelling of the Group's quarterly results. This document includes a reminder on various non-comparable items and exclusivity losses as well
BloombergSanofi Seeks Initial Offers for Its $20 Billion Consumer Arm
(Bloomberg) -- Sanofi SA has called for initial bids for its $20 billion consumer health division, as the French pharmaceutical giant simultaneously moves forward with preparations for a possible listing of the business, according to people familiar with the matter. Most Read from BloombergYouTuber Dr Disrespect Was Allegedly Kicked Off Twitch for Messaging MinorNvidia Rout Takes Breather as Traders Scour Charts for SupportTrump Could Actually Lose Florida. Here’s Why.Rivian Gets $5 Billion Life
ZacksNovavax (NVAX) Seeks Nod for Updated COVID-19 Jab in Europe
Novavax (NVAX) seeks marketing authorization in the European Union for an updated version of its COVID-19 vaccine, which has been formulated to target the JN.1 variant.
